Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients [Phase 2, Phase 3]
A Phase 2/3 trial is planned to compare Otezla (apremilast) and the investigational SFA-002 to placebo for plaque psoriasis, with the study …
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: A Study to Test How Well Different Doses of BI 765250 Are Tolerated by People With a Skin Disease Called Plaque Psoriasis [Phase 1]
A Phase 1 trial assessing tolerability of multiple doses of BI 765250 in people with plaque psoriasis; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients
A completed clinical trial investigating serum, cellular, and imaging biomarkers of arthritis in psoriasis patients.
-
EMA approval · 2025-03-03EMA Authorised: Nepexto (etanercept) — Biosimilar Collaborations Ireland Limited
EMA authorised Nepexto, a biosimilar of etanercept, developed by Biosimilar Collaborations Ireland Limited, for several inflammatory arthrit…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Phase 2 Study of Efficacy and Safety of AK111 in Subjects With Moderate-to-Severe Psoriasis [Phase 2]
An update on a Phase 2 trial evaluating AK111 for moderate-to-severe psoriasis; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: A Study of AK111 in Healthy Subjects [Phase 1]
Phase 1 trial evaluating AK111 in healthy subjects has completed. Psoriasis is listed as the condition in the study details.
-
FDA approval · 2025-02-26FDA Approved: FLUOCINONIDE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved fluocinonide from Quagen Pharmaceuticals LLC under an Original Application (ANDA 216389). This is a generic topical corticoster…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis [Phase 3]
Phase 3 trial updating the efficacy comparison between Calcipotriol plus Betamethasone Gel and Calcipotriol Scalp Solution for scalp psorias…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of calcipotriene/betamethasone gel/ointment for psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Scalp Psoriasis [Phase 3]
Phase 3 trial update reporting on the efficacy and safety of Calcipotriol plus Betamethasone Dipropionate Gel for scalp psoriasis.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of a fixed-dose gel combining calcipotriol and betamethasone dipropionate in scalp…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Cromoglicate in Psoriasis [Phase 2]
Phase 2 clinical trial of cromoglicate for psoriasis has completed (status: completed) according to ClinicalTrials.gov; results are not summ…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Dermatopharmacokinetic Trial of LEO 80185 Gel [Phase 1]
Phase 1 dermatopharmacokinetic trial of LEO 80185 Gel completed in psoriasis, evaluating skin pharmacokinetics.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris [Phase 4]
Phase 4 clinical trial updating on the efficacy and safety of Calcipotriol Cream and Calcipotriol plus Betamethasone Dipropionate Ointment i…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of calcipotriol plus betamethasone gel for scalp psoriasis has completed. The update provid…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis. [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacodynamics of a new administration form of Calcipotriol/Betamethone Dipropionate in…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Ointment in Patients With Psoriasis Vulgaris [Phase 4]
Phase 4 trial evaluating the efficacy and safety of a calcipotriol plus betamethasone dipropionate ointment in psoriasis vulgaris has comple…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects [Phase 1]
Phase 1, double-blind, placebo-controlled study of LEO 22811 in healthy subjects completed, assessing safety and pharmacokinetics after sing…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)
This clinical trial update notes the completion of a study evaluating the fixed combination of calcipotriol and betamethasone dipropionate (…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Tunisian National Registry on Psoriasis
Clinical trial update for the Tunisian National Registry on psoriasis; the study status is completed with sponsor Dacima Consulting.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or Psoriasis
A clinical trial evaluating glucocorticoid-induced osteoporosis in patients with chronic inflammatory rheumatic diseases or psoriasis; curre…
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis [NA]
A clinical trial comparing ixekizumab to secukizumab in patients over 70 with psoriasis is not yet recruiting. Sponsor: Second Affiliated Ho…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis
A completed analysis of birth outcomes among Swedish, Danish, and Finnish women exposed to Remicade (infliximab) during pregnancy across inf…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
A pregnancy exposure registry studying safety of ustekinumab (Stelara) and guselkumab (Tremfya) during pregnancy in autoimmune diseases; the…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Apremilast Pregnancy Exposure Registry
This is a pregnancy exposure registry for apremilast. The study is active but not recruiting.